Post-approval studies (Phase 4)Study completedNCT03431142
What this trial is testing
Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial
Who this might be right for
Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage
Shenyang Northern Hospital 7,758